Concepcion De-la-Camara
Overview
Explore the profile of Concepcion De-la-Camara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Segura A, Prohens L, Julia L, Amoretti S, RIbero M, Pino-Camacho L, et al.
Eur Neuropsychopharmacol
. 2025 Feb;
94:4-15.
PMID: 39956014
Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed...
2.
Lo J, Crawford J, Lipnicki D, Lipton R, Katz M, Preux P, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2437133.
PMID: 39356504
Importance: Poststroke cognitive impairment is common, but the cognitive trajectory following a first stroke, relative to prestroke cognitive function, remains unclear. Objective: To map the trajectory of cognitive function before...
3.
Zhao X, Xu X, Yan Y, Lipnicki D, Pang T, Crawford J, et al.
Lancet Reg Health West Pac
. 2024 Sep;
51:101198.
PMID: 39308753
Background: Cardiometabolic multimorbidity (CMM) and depression are often co-occurring in older adults and associated with neurodegenerative outcomes. The present study aimed to estimate the independent and joint associations of CMM...
4.
Lennon M, Lipnicki D, Lam B, Crawford J, Schutte A, Peters R, et al.
Neurology
. 2024 Aug;
103(5):e209715.
PMID: 39141884
Background And Objectives: Previous randomized controlled trials and longitudinal studies have indicated that ongoing antihypertensive use in late life reduces all-cause dementia risk, but the specific impact on Alzheimer dementia...
5.
Moreno-Juste A, Poblador-Plou B, Ortega-Larrode C, Laguna-Berna C, Gonzalez-Rubio F, Aza-Pascual-Salcedo M, et al.
PLoS One
. 2024 Feb;
19(2):e0298195.
PMID: 38346044
The COVID-19 pandemic has created unprecedented challenges for health care systems globally. This study aimed to explore the presence of mental illness in a Spanish cohort of COVID-19-infected population and...
6.
Lennon M, Lam B, Lipnicki D, Crawford J, Peters R, Schutte A, et al.
JAMA Netw Open
. 2023 Sep;
6(9):e2333353.
PMID: 37698858
Importance: The utility of antihypertensives and ideal blood pressure (BP) for dementia prevention in late life remains unclear and highly contested. Objectives: To assess the associations of hypertension history, antihypertensive...
7.
Gong J, Harris K, Lipnicki D, Castro-Costa E, Lima-Costa M, Diniz B, et al.
Alzheimers Dement
. 2023 Feb;
19(8):3365-3378.
PMID: 36790027
Introduction: Sex differences in dementia risk, and risk factor (RF) associations with dementia, remain uncertain across diverse ethno-regional groups. Methods: A total of 29,850 participants (58% women) from 21 cohorts...
8.
Lobo E, Gracia-Garcia P, Lobo A, Saz P, De-la-Camara C
Int J Environ Res Public Health
. 2021 Jul;
18(13).
PMID: 34281039
Great inter-individual variability has been reported in the maintenance of cognitive function in aging. We examined this heterogeneity by modeling cognitive trajectories in a population-based longitudinal study of adults aged...
9.
Vaquero-Puyuelo D, De-la-Camara C, Olaya B, Gracia-Garcia P, Lobo A, Lopez-Anton R, et al.
Int J Environ Res Public Health
. 2021 Feb;
18(4).
PMID: 33546118
(1) Introduction: Dementia is a major public health problem, and Alzheimer's disease (AD) is the most frequent subtype. Clarifying the potential risk factors is necessary in order to improve dementia-prevention...
10.
Amoretti S, Verdolini N, Mezquida G, Rabelo-da-Ponte F, Cuesta M, Pina-Camacho L, et al.
Eur Neuropsychopharmacol
. 2021 Feb;
47:112-129.
PMID: 33531261
The extreme variability in symptom presentation reveals that individuals diagnosed with a first-episode psychosis (FEP) may encompass different sub-populations with potentially different illness courses and, hence, different treatment needs. Previous...